The net income of Pfizer stood at some ***** billion U.S. dollars in 2024. In the preceding year, the net income was at over *** billion U.S. dollars. What factors affect net income? Companies discover how much they have earned or lost during an accounting period by analyzing their net income. For example, rising costs are among several reasons for the significant fall in Pfizer’s net income in 2020: the company increased its research and development expenditure, and suffered additional costs associated with the restructuring of the organization. It is worth adding that the high net income in 2017 was favorably impacted by a tax benefit of around **** billion U.S. dollars. The pros and cons of mergers and acquisitions Mergers and acquisitions are a common business strategy used by companies looking to grow. ***** of the largest deals in pharmaceutical industry history involve Pfizer, including its acquisition of Warner-Lambert for a record fee of around ** billion U.S. dollars in 2000. Advantages of the tactic include a larger workforce, increased spending budgets, and breaking into new markets. However, a failure to anticipate potential problems can be damaging to a company. For instance, the integration may disrupt current business operations, and inconsistencies may start to appear in standards and procedures.

Pfizer reported $2.91B in Net Income for its fiscal quarter ending in June of 2025. Data for Pfizer | PFE - Net Income including historical, tables and charts were last updated by Trading Economics this last September in 2025.

Pfizer generated a net income of over eight billion U.S. dollars in 2024. The company reported basic net earnings per common share of 1.42 U.S. dollars. The impact of rising costs on earnings per share The net income of Pfizer dramatically increased around fourfold between 2023 and 2024, evident in the company’s net earnings per share, which increased by over one U.S. dollar. Rising research and development costs can be a contributing factor in the decrease in the net income. In relation to revenues, the pharmaceutical industry is one of the biggest investors in research and development. Revenues increased due to COVID-19 vaccine Thanks to record-breaking sales of COVID-19 vaccine Comirnaty, Pfizer generated its highest total revenues in the years 2021 and 2022. In general, the majority of Pfizer’s revenues comes from the manufacture and sale of its products, and revenues from the company’s domestic market of the United States accounts for a share of around 60 percent. Pfizer sells its pharmaceutical products in more than 125 countries worldwide, with the United States, China, and Japan being its three largest markets.

Pfizer's annual net income per employee was $99.01 K in fiscal year 2024. The net income per employeeincreased$74.77 Kfrom $24.24 K(in 2023) to $99.01 K (in 2024), representing a 308.49% year-over-year growth.

The net income of Pfizer Limited with headquarters in India amounted to **** billion Indian rupees in 2023. The reported fiscal year ends on March 31.Compared to the earliest depicted value from 2020 this is a total increase by approximately **** billion Indian rupees. The trend from 2020 to 2023 shows, however, that this increase did not happen continuously.

Pfizer Net Gelir - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Sep 2025.Data for Pfizer | Net Gelir including historical, tables and charts were last updated by Trading Economics this last September in 2025.

This statistic shows the 2025 ranking of the top 10 biotech and pharmaceutical companies worldwide, based on net income. U.S.-based company Johnson & Johnson was ranked first with a net income of **** billion U.S. dollars. Biotech and pharmaceutical companiesJohnson & Johnson and Merck & Co., both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately **** billion U.S. dollars and **** billion U.S. dollars, respectively, as of 2025. Johnson & Johnson generated some **** billion U.S. dollars of revenue in 2024. Pfizer had record-high annual revenues during the COVID-19 vaccination campaign, exceeding 100 billion U.S. dollars in 2022.

Story of a former blockbuster Lyrica was once one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some **** billion U.S. dollars in revenue.

Pfizer 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Sep 2025.Data for Pfizer | 净收入 including historical, tables and charts were last updated by Trading Economics this last September in 2025.

Pfizer is a global pharmaceutical company and among the top pharmaceutical companies in the world. Pfizer is headquartered in New York City. In 2024, the company's total revenue stood at **** billion U.S. dollars. Pfizer’s global positioning Pfizer’s products are available in many countries worldwide and as of 2024, the company had more than *** research and development projects in the pipeline. For several years, Pfizer was the top pharmaceutical company based on global prescription drug sales and is among the leading pharmaceutical companies based on research and development (R&D) spending. Pfizer’s largest segment is Innovative Health (IH). The Innovative Health business focuses on various rare diseases, vaccines, immunology and internal medicine to name a few. Pfizer’s top products In 2024, products from the Prevnar family were among Pfizer's top products based on revenue. However, Pfizer has several other drugs that are also well-known. For example, Lipitor (atorvastatin calcium) is used in the treatment of high cholesterol. Over the years, however, Lipitor revenues have been on the decline due to patent loss, yet it remains part of Pfizer’s top products. One of Pfizer’s most well-known products, Viagra (sildenafil citrate), used in the treatment of erectile disfunction, has also been on the decline with 2019 having the lowest revenues on record. The low revenues are mainly attributable to Viagra’s loss of patent exclusivity in the U.S. in December 2017.

Pfizer Чистый Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Sep 2025.Data for Pfizer | Чистый Доход including historical, tables and charts were last updated by Trading Economics this last September in 2025.

The graph compares the annual net incomes of major pharmaceutical companies in the United States for the years 2010 and 2022. The x-axis lists the companies, including Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Sanofi, Novartis, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Biogen, Viatris, and Takeda Pharmaceutical. The y-axis represents net income in billions of U.S. dollars. In 2010, Johnson & Johnson led with the highest net income of $13.34 billion, while Viatris had the lowest at $0.224 billion. By 2022, Pfizer's net income surged to $31.37 billion, becoming the highest, whereas AstraZeneca and Takeda Pharmaceutical saw significant declines to $3.29 billion and $2.05 billion, respectively. Most companies, such as GlaxoSmithKline, Merck, and AbbVie, experienced substantial increases in net income over the twelve-year period. However, some companies like Novartis and AstraZeneca faced reductions in their earnings. The data is presented in a grouped bar chart format, highlighting the changes in annual net income for each pharmaceutical company between 2010 and 2022.

Pfizer Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.Data for Pfizer | Nettoeinkommen including historical, tables and charts were last updated by Trading Economics this last August in 2025.

Pfizer 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jul 2025.Data for Pfizer | 当期純利益 including historical, tables and charts were last updated by Trading Economics this last July in 2025.

Moderna generated total revenues of some 3.2 billion U.S. dollars in 2024, a massive decrease compared to the years before. The drop was mainly due to the decreasing demand for its COVID-19 vaccine Spikevax. Working hard to produce the first 'blockbuster' Moderna is a clinical stage biotech company that is pioneering messenger RNA (mRNA) therapeutics and vaccines. Beside its COVID-19 vaccine, the company is yet to generate revenues from the sale of potential drugs, and this will remain the same until it successfully completes clinical development and obtains regulatory approval for one of its medicines. Like many other biotech companies, Moderna invests significant amounts of money into research and development projects, and annual costs continue to grow. One of the very first COVID-19 vaccines approved Moderna, in partnership with the National Institutes of Health (NIH) and the Coalition for Epidemic Preparedness Innovations (CEPI), was one of the very first to develop a vaccine to fight COVID-19. The vaccine codenamed mRNA-1273 – designed and manufactured in only 25 days – prevents future infections of the novel coronavirus that has caused the pandemic. The Moderna vaccine successfully went through all necessaryclinical phases, and was the second vaccine - after the Biontech/Pfizer vaccine - to be approved for widely usage already in late 2020.

Pfizer’s worldwide known erectile dysfunction product Viagra generated around 500 million U.S. dollars in revenue in 2019. Sales of this drug have decreased steadily over the past seven years, especially because patent protection expired outside the U.S. in 2012. In the United States, several drug manufacturers are currently allowed to market generic versions of Viagra (sildenafil), even if the patent is set to expire in 2020. This was the reason behind a further significant decline in sales in 2017-2018.

Drug manufacturer Pfizer
Drug manufacturer Pfizer is currently the world’s leading pharmaceutical company based on pure pharmaceutical sales of prescribed and over-the-counter drugs. The company is headquartered in Midtown Manhattan, New York City. Until 2013, the company also had a notable animal health product line. Today, the company is totally focused on human medicine, divided into two major segments - Innovative Health and Essential Health. Pfizer generates nearly half of its revenues inside the United States.

The rise of Viagra
Viagra was developed by scientists that were originally working on a drug for the treatment of hypertension and angina pectoris. During one of the trial phases the ‘adverse effect’ became obvious – while the targeted angina pectoris showed no improvement. Thus, it was approved for the market as an orally administered drug for erectile dysfunction in 1998. Pfizer’s Viagra has surely been one of the best-known and most discussed pharmaceutical products over the last few decades, entering even popular culture and becoming a synonym for potency. The drug, however, is also approved for treating pulmonary arterial hypertension.

Pfizer 당기 순이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Sep 2025.Data for Pfizer | 당기 순이익 including historical, tables and charts were last updated by Trading Economics this last September in 2025.

Novo Nordisk's Cagrisema was the most valuable research and development project in the pharmaceutical industry worldwide, based on its net present value (NPV) of ** billion U.S. dollars, as of May 2024. Global R&D spending In 2023, global pharmaceutical industry expenditures for research and development amounted to over *** billion U.S. dollars. Total global R&D expenditures have been increasing with each consecutive year since 2012. Some of 2023’s leading pharmaceutical companies, in terms of R&D spending, included Merck, Roche, and Johnson & Johnson. Pfizer Pfizer is one of the world’s largest pharmaceutical corporations. Based in New York City, the American company generates a considerable amount of its revenue in the United States. In 2023, Pfizer earned some ** billion U.S. dollars’ worth of revenue in its U.S. American submarket, and around ** billion in emerging markets.

During 2019, Pfizer’s Lipitor generated nearly *********** U.S. dollars of revenue. For around a decade cholesterol-lowering drug Lipitor was one of the company’s top blockbusters, with record-high revenues of approximately ********** U.S. dollars in 2006. In the year of patent loss – 2011 – Lipitor still generated roughly ********** dollars, before a heavy drop down to ************ dollars in 2012. Pharmaceutical company Pfizer Drug manufacturer Pfizer is headquartered in Midtown Manhattan, New York City. At this moment, it is the world’s leading pharmaceutical company based on pharmaceutical sales of prescribed and over-the-counter drugs. Today, the company is focused on human medicine, divided into two major segments - Innovative Health and Essential Health. However, until 2013 the company also had a notable animal health division which was spun-off and today is known as Zoetis. Facts about Lipitor/atorvastatin Lipitor was approved by the FDA (Food and Drug Administration) in 1996 for medical use. Since its patent protection expired in 2011, it is now also sold under its generic name atorvastatin. Today, atorvastatin is one of the most prescribed drugs in the United States. The drug is primarily used as prevention for people with a high risk for developing cardiovascular diseases and as a treatment for abnormal lipid levels (dyslipidemia). Generic versions of Lipitor lead to annual savings in drug spending of around ********** U.S. dollars.

Die Statistik zeigt den Gewinn je Aktie des Pharmaunternehmens Pfizer in den Jahren 2008 bis 2024. Der Konzern erwirtschaftete im Jahr 2024 einen Gewinn je Aktie (net income per share attributable to Pfizer Inc. common shareholders) von **** US-Dollar.

As of early March 2025, Eli Lilly had a market cap of over *** billion U.S. dollars and thus was the leader among big pharma companies based on market capitalization. The massive rise of Eli Lilly's market value, which started in 2023, is based in a large part on its strong pipeline. This statistic depicts the top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2025. Biotech and pharmaceutical companiesPharmaceutical companies are best known for manufacturing pharmaceutical drugs. These drugs have the aim to diagnose, to cure, to treat, or to prevent diseases. The pharmaceutical sector represents a huge industry, with the global pharmaceutical market being worth more than *** trillion U.S. dollars. Among the best known top global pharmaceutical players are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Most of these companies are involved not only in pure pharmaceutical business, but also manufacture medical technology and consumer health products, vaccines, etc. For example, Johnson & Johnson makes most of its revenues through medical devices, diagnostics and consumer health products. There are both pure play biotechnology companies and pharmaceutical companies which, among other products, also produce biotech products within their biotechnological divisions. Most of the leading global pharmaceutical companies have biopharmaceutical divisions. Although not a pure play biotech firm, Roche from Switzerland is among the leaders by revenues from biotech therapies worldwide. In contrast, California-based company Amgen is the world’s largest pure-play biotech company. Amgen made over ** billion U.S. dollars of revenue in 2024. Biotech companies use biotechnology to generate their products, most often medical drugs or agricultural genetic engineering. The latter segment was dominated by Monsanto, nowadays a part of Bayer CropScience. The United Nations Convention on Biological Diversity defines biotechnology as follows: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use." In fact, biotechnology is thousands of years old, used in agriculture, food manufacturing and medicine.